| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52.6M | — | +41.3% |
| Cost of Revenue | $10.4M | — | +12.5% |
| Gross Profit | $42.2M | — | +50.9% |
| R&D Expense | $21.6M | — | +55.3% |
| SG&A Expense | $42.6M | — | +35.0% |
| Operating Income | -$29.5M | — | -68.6% |
| Pre-tax Income | -$27.4M | — | +15.4% |
| Income Tax | $23K | — | — |
| Net Income | -$27.4M | — | +15.4% |
| EPS (Basic) | -$0.32 | — | +93.9% |
| EPS (Diluted) | -$0.32 | — | +93.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.7M | -56.1% | -82.1% |
| Short-term Investments | $138.6M | +5.0% | — |
| Accounts Receivable | $35.5M | +21.1% | — |
| Current Assets | $211.8M | -3.8% | — |
| Total Assets | $344.0M | -4.3% | — |
| Current Liabilities | $38.0M | -10.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.1M | — | -128.6% |
| Capital Expenditures | $1.9M | — | +71.6% |
| Investing Cash Flow | -$1.4M | — | -29.6% |
| Financing Cash Flow | $6.2M | — | -91.6% |
| Free Cash Flow | -$32.0M | — | -124.2% |
| — |
| Total Liabilities | $58.3M | -0.8% | — |
| Stockholders' Equity | $285.7M | -5.0% | +132.1% |